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1. Introduction 
Glaucoma is a degenerative and progressive pathology involving the optic nerve with 
consequent loss of the visual field: it is a particularly severe ocular affection constituting the 
second cause of blindness in the world. This disease may occur at any age even though it is 
more frequently found in senior people (Quigley, 1987; Morgan, 2000). Five different types 
of the disease have been described: two of them are defined as primary open angle or, 
alternatively, closed angle, which is possibly the most common one (Joseph & Grienson, 
1994). Retinal gangliar cells were reported to be the ones mainly damaged by the disease as 
shown in classical studies by Quigley (Quigley et al., 1998). The disease causes a reduction of 
the axons forming the optic nerve (Capaccioli et al., 1998). The etiology of glaucoma may be 
due to two different types of damage: either mechanical or ischemic. In any case, it is 
commonly accepted that an increased intraocular pressure represents a major risk factor in 
the development of the disease, and actually, it may be one of the principal causes (Quigley 
et al., 1994; De Gregorio et al., 1997; Sommers et al., 1991; Friedman et al., 2004). Under the 
clinical point of view, the increase of pressure is apparently attributable to the alteration of 
the ocular hydrodynamics, which determines a normal efflux of the aqueous humor from 
the anterior chamber. Different types of glaucoma exist in particular, in the case of the open 
angle glaucoma, the lack of efflux depends particularly on obstructions in the trabecular 
network, while the primary closed angle glaucoma involves a modification the irido-corneal 
angle. Other ocular pathologies exist where the vitreous efflux is altered but, in these cases, 
the pathology is defined as secondary glaucoma: also in this pathological condition, the 
open and the closed angle have been described. In any case, the elevated intraocular 
pressure seems to be the most relevant pathogenic phenomenon determining the 
neuropathy although it may be not the only one (Quigley et al., 1994; De Gregorio et al., 1997; 
Sommers et al., 1991). With respect to this, the synergic action of other factors seems to be 
proved by the existence of glaucomatous pathologies occurring in conditions of normal 
ocular pressure: however, a reduced retinal and optic nerve perfusion could play a role due 
to a deficient blood delivery to these ocular structures. The immunological aspect of the 
disease should be also considered: for instance in glaucoma patients several auto-immuno 
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markers were detected (Wax et al., 2000). However, the role of the humoral immunity is far 
from clear, even though the immuno-system could play a role in the development and/or 
progression of the pathological condition (Pescosolido et al., 2008). In the light of the aspects 
so far discussed, it is plausible assuming that the immune system plays an active role in 
triggering the neuro-degenerative process, which could be very likely, started by the glial 
cells. These, by producing cytokines and presentation of antibodies, lead to the elicitation of 
cytotoxic autoantibodies as previously discussed (Calandrella et al., 2010).  
In our laboratory, we developed an effective experimental rat model of acute ocular 
hypertension where the hyper-tone was induced by injection of methylcellulose in the 
anterior chamber. This inert non-immunogenic substance clogs the Schlemm’s canals thus 
causing the accumulation of aqueous humor with consequent increase of intra-ocular 
pressure: therefore, the pathological conditions found in the human glaucoma are 
reproduced. The increased intra-ocular pressure (IOP) eventually determines a damage at 
the level of the retinal cells which can be controlled by L-carnitine, a well known peroxide 
scavenger (Calandrella et al., 2007; Calandrella et al. 2010). In this work, we focus on the 
morphological and functional alterations of the ocular nervous structures consequent to the 
hypertensive stress. In particular, we have examined the possibility that L-carnitine can 
antagonize the damage due to the production of free radicals that are formed in significant 
amounts during a situation of ischemia/re-perfusion. In other words, we probed the 
hypothesis that L-carnitine may play an anti-apoptotic role via the improvement of the 
mitochondrial performance and the stabilization of the membrane of this cell organelle (Ishii 
et al., 2000). To this end, we present data on the on the alterations of the expression of the 
Matrix-Metallo-Proteases (MMP) -2 and -3. These enzymes are involved, respectively, in the 
degradation of type IV collagen and of a wide range of proteins of the extracellular matrix 
such as fibronectin, proteoglycans and lamin. We also present results on the level of 
expression of the inducible Nitric Oxide Synthase (iNOS), one of the principal enzymes 
responsible for the production of free radicals in the retina and optic nerve subjected to the 
hypertensive shock. To ascertain the actual extent of oxidative damage we also measured 
the level of membrane lipo-peroxidation and, finally, we assessed the mode of cell death by 
the evaluation annexin V, an early marker of apoptosis and caspase-3, a protease executing 
the apoptotic death program. 
2. Materials and methods 
2.1 Animals and induction of the hyper-tone  
We used 5 different male Wistar rats (weight 300-500 grams) in each experimental session. 
In every animal, one eye was subjected to the treatment while the contra-lateral one 
represented the untreated sham-operated control. The experimental model of hyper-tone 
induction was derived from the one published by Zhu and Cai in rabbits but adapted to rats 
(Zhu & Cai 1992). Where applicable, L-carnitine (obtained from Sigma-Tau, Italy) was used 
at 0,6 mM (concentration which refers to the solution applied to the animal’s eye). Animals 
were sacrificed at the indicated time post-treatment by carotid haemorrhage and the eyes 
were enucleated for analysis. The cornea was eliminated at the level of the corneal limbus 
and emptied of the crystalline lens and aqueous humor. 
For details about methyl-cellulose injection, time course and measurement of the ocular 
hyper-tone, local and general anesthesia as well as surgical manipulations see: (Calandrella 
et al., 2007; Calandrella et al., 2010). 
www.intechopen.com
Role of the Matrix Metallo-Proteinases  
in the Cellular Re-Modeling in a Glaucoma Model System in Rat 
 
53 
2.2 Cell biology assays 
Immunolocalization was performed as previously reported (Calandrella et al., 2007). 
Immuno-histochemical assays were used to assess the level of Matrix-Metallo-Proteases 2 e 
3 (MMP-2 MMP-3), inducible Nitric Oxide Synthase (iNOS), annexinV and caspase-3; for 
details see (Calandrella et al., 2007; Calandrella et al., 2010). Immunohistochemistry samples 
were fixed and stored at -20° for subsequent microscopy observation. 
2.3 Biomolecular assays 
Western blottings and lipoperoxidation assays were performed on control and carnitine 
treated retinal cell extracts. Total protein extracts were prepared by standard procedures 
and analyzed by PAGE using the following antibodies: caspase 3 (active form), iNOS (Santa 
Cruz) and ubiquitin (Sigma-Aldrich). Actin was used as standard reference (Sigma-Aldrich). 
To determine the oxidative stress at membrane level we used a quantitative assay based on 
the intracellular production of malonyl-dialdehyde (MDA, commercial kit LPO-586 Oxis 
Health Research Products Portland, Or. USA). The reaction of a single MDA molecule with 
NMP molecules generates a stable chromophore whose absorbance is measured at a 586 nm. 
Absorbance values can be directly converted in molar concentration of MDA.  
2.4 Statistical analysis 
All the experiments were repeated at least three times. Statistical analysis of the results was 
made by the Student’s t-test or by a two-way analysis of variance (ANOVA) followed by the 
Student’s t-test. P-values <0.05 were considered significant. Ocular inflammation was 
evaluated by the Drize test (Drize, 1944). The experimentation was performed according the 
guidelines ARVO (Association for Research in Vision and Ophthalmology). In any case, this 
research was conducted according to the International Guiding Principles for Biomedical 
Research Involving Animals recommended by WHO on animal research; all Italian and 
European regulations on animal research were also respected. 
3. Results and discussion 
3.1 Alterations of the extracellular matrix: Role of Matrix-Metallo-Proteases (MMP -2 
and 3) 
As previously shown in our laboratory, in the glaucomatous pathology an extensive matrix 
remodeling is observed at the level of the head of the optic nerve; this is associated to the 
increase of intra-ocular pressure (Calandrella et al., 2007; Calandrella et al., 2010). 
Remodeling of the extra-cellular matrix, induced by neural damage, is mediated by the 
MMPs which are normally regulated by specific inhibitors known as TIMPs. These enzymes 
are expressed in a constitutive manner in the retina, in particular in the retinal gangliar cells 
(RGC), while in the optic nerve MMPs are expressed by astrocytes. This suggests their 
involvement in the maintenance of the synaptic integrity and plasticity as well as the peri-
axonal space. In a first series of experiments, we assessed the matrix re-modeling by 
immunolocalization of MMP-2 and MMP-3. Data presented in Figure 1 show that 
methylcellulose (MTC) induces a drastic increase of the MMP-2 expression in the retina 
(Right upper panel). The fluorescent reaction is strongly reduced by contemporary injection 
of MTC and L-Carnitine (Center lower panel) thus suggesting the protective role of this 
drug.  
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Fig. 1. Increase of the MMP-2 expression in the retina as shown by fluorescent reaction 
(Right upper panel), which is strongly reduced by contemporary injection of MTC and L-
Carnitine (Center lower panel). The left upper panel refers to untreated control eyes. 
We obtained similar results also after immunolocalization of the MMP-3 (Figure 2, Left 
upper panel and lower center panel, respectively); actually, the expression of this enzyme is 
significantly reduced in the presence of L-carnitine.  
The molecular target of the two MMPs is different since the first one cleaves type IV 
collagen while the second one degrades a broader range of proteins such as fibronectin, 
laminine and proteoglycans (Woessner, 1991). We monitored analogous results in  
immunolocalization analysis of the optic nerve, also in the over-expression of MMPs whose 
reduction is mediated by L-carnitine. Interestingly, the columnar organization of the 
astrocytes is lost after treatment with MTC but is moderately restored by L-carnitine. With 
respect to this, the presence of an increased expression of the MMPs was previously 
observed in the vitreous and cultured cells of the trabecular network. Actually, data from 
other laboratories suggest that, due the broad range of substrates processed by MMP-3, the 
over-expression of this enzyme is per se sufficient to cause re-modeling of the trabecular 
tissue in the open angle glaucoma after ex vivo reperfusion of the eye (Pang et al., 2003). 
Therefore, the original data is that in our case matrix remodeling is also observed in the 
posterior area of the eye.  
From these results, we can draw a first conclusion: L-carnitine can counteract the effects of 
the hypertone due to the injection MTC. In other words, the extracellular matrix remodelling 
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can be controlled by the cytoprotective action of L- carnitine, which improves the membrane 
stability and consequently, leads to better interactions between the cell and the extracellular 
matrix. 
 
 
  
 
 
 
 
 
Fig. 2. Immunolocalization of the MMP-3 after treatment with MTC (Right upper panel). 
The expression of this enzyme is significantly reduced in the presence of L-carnitine (Lower 
center panel). Left upper panel is as in Figure 1. 
3.2 Oxidative stress as a consequence of the acute ocular hypertension 
The cellular damage due to the hypoxi/re-oxigenative stress may trigger the production of 
free radicals with consequent destabilization of the cell membranes (Calandrella et al., 2010). 
As a matter of fact literature data show that the ischemic insult at retinal level activates 
iNOS which leads to the production of nitrogen oxide (Goldstein et al., 1995; Geyer et al., 
1995): this compound is cytotoxic at high concentration and causes lipid peroxidation (Crow 
et al., 1996; Ullrich et al., 2000). It was also shown that iNOS expression is responsible for the 
retinal cell death both in vitro and in vivo (Sennlaub et al., 2002). In the light of these data, we 
evaluated the level of this enzyme as a consequence of the hypertensive shock caused by 
MTC and if its expression could be modulated by parallel administration L-carnitine. The 
experimental approach is essentially analogous to the one adopted for the determination of 
MMP-2 and -3 (the results of immunolocalization assays are not shown). We also carried a 
Western blot evaluation of the iNOS level. It worth noting that, unlike the previous 
immunolocalization assays, the Western blot allows a simpler and more immediate 
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quantification of the iNOS concentration. Results show (Figure 3) that in protein extracts of 
retina, a protein band of 130 kDa is observed representing the iNOS already hours 6 after 
the treatment with MTC (immunoblot at 24 hours is omitted). The actin band (50 kDa) was 
used as reference standard in this and the following Western blotting assays.  
This indicates that the up-regulation of iNOS and the consequent production of nitric oxide, 
are early reactions to the hypertensive shock. As expected in the animals treated also with L-
carnitine the enzyme immuno-band is significantly reduced. This validates the idea that the 
drug exerts a strong cytoprotective action during the re-oxigenation and reperfusion process 
(Mutomba et al., 2000; Di Marzio et al., 1997; Pillich et al., 2005). Similar results were obtained 
24 hour after the treatment. The data are quantified in Figure 4. 
 
 
 
 
 
 
Fig. 3. Treatment of the rat eye with MTC for 6 hours induces a strong induction of the iNOS 
(Upper panel, center lane) as compared to the control eye where the iNOS band is decreased 
(Upper panel, left lane). This over-expression is reduced significantly by contemporary 
treatment with L-carnitine (Upper panel, right lane). The lower panel refers to the actin 
immunoreaction used as standard (See Figure 4). 
 
 
 
 
Fig. 4. Quantification of the Western blotting data presented in figure 3. Quantification 
refers both to 6 and to 24 hours post-treatment. 
In the light of these results, we also assessed the level of lipid peroxidation, which is 
commonly accepted as an indicator of oxidative stress in cultured cells and in tissues (Petit 
et al., 1995; Chancerelle and Kergonou, 1995). This assay is based on the quantitative 
evaluation of the intracellular concentration of malonyl-dihaldeyde (MDA). This compound 
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is not normally present in the cells but is formed after an oxidative stress and is also 
considered a marker of membrane damage; as a matter of fact MDA is one of the main 
products of the decomposition of poly-unsaturated fatty acids.  
The lipoperoxidation assay, performed three hours after the treatment with MTC (Fig 5, 
central bar), indicates a dramatic increase of the MDA concentration as compared to control 
retinas (left bar). However, the production of this compound is significantly reduced if MTC 
is administered to the rat in the presence of L-carnitine. This validates the idea that L-
carnitine stabilizes the lipid membrane and improves the mitochondrial performance. The 
final result is the reduction of the lipid peroxidation derived by the hypertensive shock.  
 
 
 
 
Fig. 5. Lipoperoxidative damage induced by MTC (Central bar) treatment is drastically 
reduced by L-carnitine (Right bar).  
3.3 Mechanisms of programmed cell death: expression of annexin V and caspase-3 
In this final series of experiments, we monitored the level of two different apoptotic 
markers: annexin V and caspase -3. The rationale of these experiments was that in the early 
stages of apoptosis the phospho-lipid symmetry of the membrane is altered; annexin V is 
included in a family of proteins known to bind phospholipids in the presence of Ca2+ ions. 
In particular, it interacts with phosphatidyl-serine, which is translocated to the outer face of 
the membrane thus becoming a recognition signal for phagocytes (Lazebnick et al., 1994). 
We evaluated the expression of this early marker of apoptosis by immuno-blotting, both 
after treatment of the eye with MTC only, or MTC in the presence of L-carnitine.  
The level of annexin V was normalized to the one of actin, which is expressed in a 
constitutive fashion. Results of Figure 6 clearly show that contemporary treatment with 
MTC and L-carnitine reduces significantly the level of annexin V already 6 hours post-
treatment (the immunoblot picture is reported only for the treatment time at 6 while the 
quantitative analysis refers both to 6 and 24 hour treatment). The low level of Annexin V 
monitored after 24 hours of treatment (immunoblot not shown, quantification in Figure 7) is 
possibly due to the advanced phase of apoptosis since this marker is expressed mainly in the 
early phases of the process (Lazebnick et al., 1994).   
The low level of annexin V observed also in untreated eyes may be ascribed to the 
“physiological” expression on this protein as observed previously or, alternatively, to a 
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generic damage inflicted to the eye while carrying out the experimental protocol 
(Calandrella et al., 2010).  
 
 
 
 
 
 
 
Fig. 6. Expression annexin V both after treatment of the eye with MTC only (Center lane), or 
MTC in the presence of L-carnitine (Right lane). Also in this case as in the previous figure, 
actin (Lower panel) was used as reference standard for the quantification reported below. 
 
 
 
 
 
Fig. 7. Levels of annexin V after treatment with MTC or MTC plus carnitine. Also in this case 
as in the previous figure actin was used as reference standard. 
Caspase-3 is the enzyme responsible for the execution of the final phases of apoptosis. 
Therefore, the Western-blot analysis was performed both after 6 and 24 hours of treatment 
with MTC (or in association with L-carnitine). This experiment allows also evaluating 
whether L-carnitine is able to reduce the apoptotic death by modulating in a negative 
fashion the expression of caspase-3 (Mutomba et al., 2000, Calandrella et al. 2007). Data 
reported in Figure 8 (Upper panel, right lane) clearly show that the expression of caspase-3 
in retinal cell extracts is strongly reduced at 24 hours after the treatment with MTC in the 
presence of L-carnitine.  
However, 6 hours after the treatment the level of caspase-3 is practically identical to control 
samples. This suggests that L-carnitine acts also in advanced stages of the apoptotic process 
but prior to irreversibility. 
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Fig. 8. The expression of caspase-3 (Center lane) in retinal cell extracts is strongly reduced at 
24 hours after the treatment with MTC in the presence of L-carnitine (Right lane). Actin 
(Lower panel) was used as reference standard for the quantification reported below. 
 
 
 
Fig. 8. Quantification of the data in the previous figure (normalized to actin). 
4. Conclusions 
In this study, we induced the hypertensive stress inoculating methyl-cellulose in the anterior 
chamber of the eye in a rat model system. This mimics the pathological situation occurring 
in the human glaucoma (Calandrella et al., 2010). The results of our investigations 
demonstrate that L-carnitine, a well known scavenger of reactive peroxides (Pollit, 1995; 
Stephens et al., 2007), can exert a cytoprotective action which involves the reduction of the 
expression of metalloprotease -2 and -3. We also monitored a down-regulation of typical 
apoptotic markers such as annexin V and caspase 3. The decrease of the level of iNOS, 
induced by L-carnitine and the consequent reduction of intracellular MDA finally suggests 
that this compound may also limit the damage due to the oxidative stress. In conclusion, 
these results may be very useful in the elucidation of the pathological and molecular 
phenomena occurring during the progression of the human glaucoma. Also, these data may 
open the way to a possible solution of this pathological condition. 
5. References  
Calandrella, N.; De Seta, C.; Scarsella, G. & Risuleo, G. (2010). Carnitine reduces  
the lipoperoxidative damage of the membrane and apoptosis after induction of  
cell stress in experimental glaucoma. Cell Death and Disease, Vol. 1, No. 8,  
www.intechopen.com
 Glaucoma – Current Clinical and Research Aspects 
 
60
(Aug 5), pp. e62, doi:10.1038/cddis.2010.40. ISSN (online): 2041-4889. On line 
publication 
Calandrella, N.; Scarsella, G.; Pescosolido, N. & Risuleo, G. (2007). Degenerative and 
apoptotic events at retinal and optic nerve level after experimental induction of 
ocular hypertension. Molec. Cell. Biochem, Vol. 301, No. 1-2, (July 2007), pp. 155-163 
Capaccioli, S.; Nucci, C.; Quattrone, A. & Carella, E. (1998). Apoptosi nel glaucoma. In: 
Apoptosi in oftalmologia, Ed  I.N.C., pp. 44-57, Roma 
Chancerelle, Y. & Kergonou, J.F. (1995). Immunological relevance of malonic dialdehyde. 
Ann. Pharm. Fr., Vol. 53, No. 6, pp. 241-50  
Crow, J.P. & Beckman, J.S. (1996). The importance of superoxide in nitricoxide-dependent 
toxicity: evidence for peroxynitrite-mediated injury. Adv. Exp. Med. Biol., Vol. 387, 
pp. 147-61 
De Gregorio, F.; Pecori Giraldi, J.; De Stefano, C. & Virno, M. (1997). Correlation between 
ocular hypertension induced by ibopamine and perimetric defect in primary open 
angle glaucoma. Eur. J. Ophthalmol., Vol. 7, No. 2, pp. 152-55  
Di Marzio, L.; Alesse, E.; Roncatoli, P.; Muzi, P.; Moretti, S.; Marcellini, S.; Amicosante, G.; 
De Simone, C. & Cifone, M.G. (1997). Influence of L-carnitine on CD95 cross-
linking-induced apoptosis and ceramide generation in human cell lines: correlation 
with its effects on purified acidic and neutral sphingomyelinase in vitro. Proc. 
Assoc. Am. Physicians, Vol. 109, No. 2, (Mar 1997), pp. 154-63 
Drize, J.H.; Woodard, G. & Calvery, H.O. (1944). Methods for the study of irritation and 
toxicity of substances applied topically to the skin and mucous membranes. J. 
Pharm. Exp. Ther., Vol. 82, pp. 377-90 
Friedman, D.S.; Wilson, M.R.; Liebmann, J.M.; Fechtner, R.D. & Weinreb, R.N. (2004). An 
evidence-based assessment of risk factors for the progression of ocular 
hypertension and glaucoma. Am. J. Ophthalmol., Rev Vol. 138, No. 3, (Sep 2004), pp. 
S19-31 
Geyer, O.; Almong, J.; Lupu-Meiri, M.; Lazar, M. & Oron, Y. (1995). Nitric oxide sinthase 
inhibitors protect rat retina against ischemic injury. FEBS Letters,  Vol. 374, No. 3, 
(Nov 1995), pp. 399-402   
Goldstein, I.M.; Ostwald, P. & Roth, S. (1995). Nitric oxide: a review of its role in retinal 
function and disease. Vision. Res., Vol. 36, No. 18, (Sep 1996), pp. 2979-94 
Ishii, T.; Shimpo, Y.; Matsuoka, Y. & Kinoshita, K. (2000). Anti-apoptotic effect of Acetyl-L-
carnitine and L-carnitine in primary cultured neurons. Jpn. J. Pharmacol., Vol. 83, 
No. 2, (Jun 200), pp. 119-24  
Joseph, J. & Grienson, I. (1994). Anterior segment changes in glaucoma. In: Pathology of  
ocular disease: a dinamic approach. Ed. Garner A. & Klintworth G.H., Marcel Dekker 
Inc. 
Lazebnik, Y.A.; Kaufmann, S.H.; Desnoyers, S.; Poirier, G.G. & Earnshaw, W.C. (1994). 
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. 
Nature, Vol. 371, No. 6495, (Sep 1994), pp. 346-7 
Morgan, J.E. (2000). Optic nerve head structure in glaucoma: astrocytes as mediators of 
axonal damage. Eye, Vol. 14, No. Pt3B, (Jun 2000), pp. 437-44 
www.intechopen.com
Role of the Matrix Metallo-Proteinases  
in the Cellular Re-Modeling in a Glaucoma Model System in Rat 
 
61 
Mutomba, M.C.; Yuan, M.; Adachi, S.; Yokoyama, C.B.; Esser, V.; McGrarry, J.D.; Babior, 
B.M. & Gottileb, R.A. (2000). Regulation of the activity of caspase by L-carnitine 
and palmitoylcarnitine. FEBS Lett., Vol. 478, No. 1-2, (Jul 2000), pp. 19-25  
Pang, I.; Fleenor, D.L.; Hellberg, P.E.; Stropki, K.; McCartney, M.D. & Clark, A.F. (2003). 
Aqueous Outflow–Enhancing Effect of tert-Butylhydroquinone: Involvement of 
AP-1 Activation and MMP-3 Expression. Invest. Ophthalmol. Vis. Sci., Vol. 44, No. 8, 
(Aug 2003), pp. 3502–3510  
Pescosolido, N.; Imperatrice, B. & Karavitis, P. (2008). Ocular disorders secondary to 
systemic disease and the potential role of carnitines. Drugs R. D., Vol. 9, No. 1, pp. 
15-22, doi: 10.2165/0126839-200809001-00003 
Petit, E.; Divoux, D.; Chancerelle, Y.; Kergonou, J.F. & Nouvelot, A. (1995). Immunological 
approach to investigating membrane cell damages induced by lipoperoxidative 
stress. Application to far UV-irradiated erythrocytes. Biol. Trace. Elem. Res., Vol. 47, 
No. 1-3, (Jan-Mar 1995), pp. 17-27 
Pillich, RT.; Scarsella, G. & Risuleo, G. (2005). Reduction of apoptosis through the 
mitochondrial pathway by the administration of acetyl-L-carnitine to mouse 
fibroblasts in culture. Exp. Cell. Res., Vol. 306, No. 1, (May 15), pp. 1-8 
Pollitt, R.J. (1995). Disorders of mitochondrial long-chain fatty acid oxidation. J. Inherit. 
Metab. Dis., Vol. 18, No. 4, pp. 473-90, Review  
Quigley, H.A.; Dunkelberger, G.R. & Green, W.R. (1989). Retinal ganglion cell atrophy 
correlated with automated perimetry in human eyes with glaucoma. Am. J. 
Ophthalmol., Vol. 107, No. 5, (May 1989), pp. 453-64  
Quigley, H.A. (1987). Reappraisal of the mechanism of glaucomatous optic nerve damage. 
Eye Vol. 1, No. Pt2, pp. 318-22 
Quigley, H.A.; Enger, C.; Katz, J.; Sommer, A.; Scott, R. & Gilbert, D. (1994). Risk factors for 
the development of glaucomatous visual field loss in ocular hypertension. Arch. 
Ophthalmol., Vol. 112, No. 5, (May 1994), pp. 644-9 
Sennlaub, F.; Courtois, Y. & Goureau, O. (2002). Inducible nitric oxide synthase mediates 
retinal apoptosis in ischemic proliferative retinopathy. J. Neurosci., Vol. 22, No. 10, 
(May 2002), pp. 3987-93 
Sommers, A.; Tielsh, J.M. & Katz, J. (1991). Relationship between intraocular pressure and 
primary open angle glaucoma among white and black Americans. Arch. 
Ophthalmol., Vol. 109, No. 8, (Aug 1991), pp. 1090-5  
Stephens, F.B.; Constantin-Teodosiu, D. & Greenhaff, P.L. (2007). New insights concerning 
the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J. 
Physiol., Vol. 581, No. Pt2, (Jun 2007), pp. 431-44 
Ullrich, V. & Bachschmid, M. (2000). Superoxide as a massanger of endothelial function. 
Biochem. Biophys. Res. Comm., Vol. 278, No. 1, (Nov 2000), pp. 1-8 Review 
Wax, M.B.; Tezel, G.; Kobayashi, S. & Hernandez, M.R. (2000) Responses of different cells 
lines from ocular tissues to elevated hydrostatic pressure. Br. J. Ophthalmol., Vol. 84, 
No. 4, (Apr 2000), pp. 423-8 
Woessner, J.F. Jr. (1991). Matrix metalloproteinases and their inhibitors in connective tissue 
remodeling. FASEB J., Vol. 5, No. 8, (May 1991), pp. 2145-54 Review 
www.intechopen.com
 Glaucoma – Current Clinical and Research Aspects 
 
62
Zhu, M.D. & Cai, F.Y. (1992). Development of experimental chronic intraocular hypertension 
in the rabbit. Austl. Nw. Z. J. Ophthalmol. Vol. 20, No. 3, (Aug 1992), pp. 225-34 
www.intechopen.com
Glaucoma - Current Clinical and Research Aspects
Edited by Dr. Pinakin Gunvant
ISBN 978-953-307-263-0
Hard cover, 376 pages
Publisher InTech
Published online 09, November, 2011
Published in print edition November, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
This book summarizes current literature about research and clinical science in glaucoma and it is a synopsis
and translation of the research conducted by individuals who are known in each of their respective areas. The
book is divided into two broad sections: basic science and clinical science. The basic science section examines
bench- and animal-modeling research in an attempt to understand the pathogenesis of glaucoma. The clinical
science section addresses various diagnostic issues and the medical, laser and surgical techniques used in
glaucoma management.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Claudio De Seta, Nicola Calandrella, Valerio Berardi, Antonio Mazzarelli, Gianfranco Scarsella and Gianfranco
Risuleo (2011). Role of the Matrix Metallo-Proteinases in the Cellular Re-Modeling in a Glaucoma Model
System in Rat, Glaucoma - Current Clinical and Research Aspects, Dr. Pinakin Gunvant (Ed.), ISBN: 978-953-
307-263-0, InTech, Available from: http://www.intechopen.com/books/glaucoma-current-clinical-and-research-
aspects/role-of-the-matrix-metallo-proteinases-in-the-cellular-re-modeling-in-a-glaucoma-model-system-in-rat
© 2011 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
